Literature DB >> 22760498

Regulatory T cells, mTOR kinase, and metabolic activity.

Claudio Procaccini1, Giuseppe Matarese.   

Abstract

The field that links immunity and metabolism is rapidly expanding. Apparently, non-immunological disorders such as obesity and type 2 diabetes have been linked to immune dysregulation, suggesting that metabolic alterations can be induced by or be a consequence of an altered self-immune tolerance. In this context, a key role is played by signaling systems acting as metabolic "sensors" linking energy/nutritional status to regulatory T (Treg) cell functions. We propose that a dynamic/oscillatory activity of intracellular metabolism, through mTOR modulation, might represent a shift in understanding the molecular mechanisms governing Treg cell tolerance. In particular, the decision between Treg cell proliferation and hyporesponsiveness arises from their ability to probe the extracellular milieu and, modulating the metabolic intracellular signaling, to determine different qualitative and quantitative functional outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760498     DOI: 10.1007/s00018-012-1058-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  132 in total

1.  Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.

Authors:  Shuling Zhang; Julie A Readinger; Wendy DuBois; Mirkka Janka-Junttila; Richard Robinson; Margaret Pruitt; Val Bliskovsky; Julie Z Wu; Kaori Sakakibara; Jyoti Patel; Carole A Parent; Lino Tessarollo; Pamela L Schwartzberg; Beverly A Mock
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

Review 2.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

3.  Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells.

Authors:  Danila Valmori; Valeria Tosello; Naira E Souleimanian; Emmanuelle Godefroy; Luigi Scotto; Yu Wang; Maha Ayyoub
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 4.  mTOR signalling and metabolic regulation of T cell differentiation.

Authors:  Christian Peter; Herman Waldmann; Stephen P Cobbold
Journal:  Curr Opin Immunol       Date:  2010-09-15       Impact factor: 7.486

5.  Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

Authors:  Eric V Dang; Joseph Barbi; Huang-Yu Yang; Dilini Jinasena; Hong Yu; Ying Zheng; Zachary Bordman; Juan Fu; Young Kim; Hung-Rong Yen; Weibo Luo; Karen Zeller; Larissa Shimoda; Suzanne L Topalian; Gregg L Semenza; Chi V Dang; Drew M Pardoll; Fan Pan
Journal:  Cell       Date:  2011-08-25       Impact factor: 41.582

6.  An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.

Authors:  Claudio Procaccini; Veronica De Rosa; Mario Galgani; Luisa Abanni; Gaetano Calì; Antonio Porcellini; Fortunata Carbone; Silvia Fontana; Tamas L Horvath; Antonio La Cava; Giuseppe Matarese
Journal:  Immunity       Date:  2010-12-09       Impact factor: 31.745

7.  Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin.

Authors:  Samik Basu; Tatiana Golovina; Tatiana Mikheeva; Carl H June; James L Riley
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

8.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

Authors:  Giovanna Borsellino; Markus Kleinewietfeld; Diletta Di Mitri; Alexander Sternjak; Adamo Diamantini; Raffaella Giometto; Sabine Höpner; Diego Centonze; Giorgio Bernardi; Maria Luisa Dell'Acqua; Paolo Maria Rossini; Luca Battistini; Olaf Rötzschke; Kirsten Falk
Journal:  Blood       Date:  2007-04-20       Impact factor: 22.113

9.  Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking.

Authors:  Linda V Sinclair; David Finlay; Carmen Feijoo; Georgina H Cornish; Alex Gray; Ann Ager; Klaus Okkenhaug; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2008-04-06       Impact factor: 25.606

10.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.

Authors:  Stephan Sauer; Ludovica Bruno; Arnulf Hertweck; David Finlay; Marion Leleu; Mikhail Spivakov; Zachary A Knight; Bradley S Cobb; Doreen Cantrell; Eric O'Connor; Kevan M Shokat; Amanda G Fisher; Matthias Merkenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-28       Impact factor: 11.205

View more
  9 in total

Review 1.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

2.  Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Georgi Vasilev; Mariana Ivanova; Ekaterina Ivanova-Todorova; Kalina Tumangelova-Yuzeir; Ekaterina Krasimirova; Rumen Stoilov; Dobroslav Kyurkchiev
Journal:  Rheumatol Int       Date:  2019-04-03       Impact factor: 2.631

Review 3.  Leptin-based adjuvants: an innovative approach to improve vaccine response.

Authors:  Sarah J White; Matthew J Taylor; Ryan T Hurt; Michael D Jensen; Gregory A Poland
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

4.  Hypoxic culture conditions enhance the generation of regulatory T cells.

Authors:  Thi My Anh Neildez-Nguyen; Jérémy Bigot; Sylvie Da Rocha; Guillaume Corre; Florence Boisgerault; Andràs Paldi; Anne Galy
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

Review 5.  The interplay between regulatory T cells and metabolism in immune regulation.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Oncoimmunology       Date:  2013-10-21       Impact factor: 8.110

Review 6.  T cell receptor (TCR) signaling in health and disease.

Authors:  Kinjal Shah; Amr Al-Haidari; Jianmin Sun; Julhash U Kazi
Journal:  Signal Transduct Target Ther       Date:  2021-12-13

Review 7.  Cytotoxicity of Metal-Based Nanoparticles: From Mechanisms and Methods of Evaluation to Pathological Manifestations.

Authors:  Peizheng Xiong; Xiangming Huang; Naijing Ye; Qunwen Lu; Gang Zhang; Shunlin Peng; Hongbo Wang; Yiyao Liu
Journal:  Adv Sci (Weinh)       Date:  2022-03-27       Impact factor: 17.521

8.  The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements.

Authors:  Claudio Procaccini; Fortunata Carbone; Dario Di Silvestre; Francesca Brambilla; Veronica De Rosa; Mario Galgani; Deriggio Faicchia; Gianni Marone; Donatella Tramontano; Marco Corona; Carlo Alviggi; Antonio Porcellini; Antonio La Cava; Pierluigi Mauri; Giuseppe Matarese
Journal:  Immunity       Date:  2016-02-16       Impact factor: 31.745

9.  Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment.

Authors:  Valentina Rubino; Anna Teresa Palatucci; Giuliana La Rosa; Angela Giovazzino; Francesco Aruta; Simona Damiano; Flavia Carriero; Mariarosaria Santillo; Rosa Iodice; Paolo Mondola; Giuseppina Ruggiero; Giuseppe Terrazzano
Journal:  Antioxidants (Basel)       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.